Comparison Of The Use Of Single Atypical Antipsychotics And Combination Atypical Antipsychotics Against LDL Levels In Schizophrenic Patients
Abstract
Abstract: Schizophrenia is a collection of psychotic disorders with irregularities in the thought process, which have the feeling that they are controlled by external forces, delusions, perceptual disorders and abnormal effects integrated with real situations or reality. The use of antipsychotics in schizophrenic patients is the treatment of this disease, especially the most commonly used atypical antipsychotic users. This study aims to compare LDL (low-density lipoprotein) levels in schizophrenia patients who use single atypical antipsychotics and combination atypical antipsychotics at Madani Hospital Medan, North Sumatra. This type of research is descriptive analytical using a cross-sectional method that takes data on variable-free bound variables at one time, which is housed at the Upt Health Laboratory. North Sumatra Provincial Health Office. The results of the Independent T-Test of the use of single antipsychotics and a combination of atypical antipsychotics on LDL levels in schizophrenia patients were p=0.001 (P≤0.05). There was a significant difference between the administration of a single atypical antipsychotic and a combination of atypical antipsychotics to LDL levels in patients with schizophrenia.
Keywords
Full Text:
PDFReferences
Padmasari S. Evaluasi Rasionalitas pada Pasien Skizofrenia di Instalasi Rawat Inap Rumah Sakit Jiwa Grhasia Yogyakarta, 2017. 2017;1(1):25–32.
Fleischhacker, W. W. & Uchida, H. Critical Review Of Antipsychotic Polypharmacy In The Treatment Of Schizophrenia. Int. J. Neuropsychopharmacol. 17, 1083–1093 2014.
Indriani A, Ardiningrum W, Febrianti Y. Studi Penggunaan Antipsikotik pada Pada pasien Skizofrenia di Rumah Sakit Yokyakarta. Majalah Farmasetika, 4 (Suppl 1) 2019, 201–211.
Manado DIK, Warouw SM. Gambaran Kadar Low Density Lipoprotein (LDL) pada Siswa-Siswi Overweight dan Obesitas. 2012;(Ldl):69–76.
Kaushal J, Bhutani G, Gupta R. Comparison of Fasting Blood Sugar and Serum Lipid Profile Changes After Treatment with Atypical Antipsychotics Olanzapin and Risperidon. 2012;53(7):488–92.
Leon JD, Susce MT, Johnson M, Hardin M, Pointer L, Ruano G, et.al. A Clinical Study of the association of antipsychotics with Hyperlipidemia. Schizophrenia Research 92(2007); 95-102.
Lee, J, Nurjono, M., Wong, A., & Salim, A. Prevalance Of Metabolic Syndrome in Patients withSchizophrenia in Singapore: A multicenter nationwide cross- sectional study. Psychiatry Investig. 2017:3(2);457–462.
Barus RF. Perbedaan Profil Lipid Yang Mendapat Pengobatan Quetiapin Extended Release Dan Risperidon Pada Orang Dengan Skizofrenia. 2017.
Makeen M, Abdeelraheem J, Osman S, Abas E, Adam KM, Abdrabo AA. Effects of Antipsychotic Drugs on Serum Biochemical Tests. Pyrex journals of Biomedical Research 2017, 1-6.
Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, infant MC, Weiden PJ. Antipsychotics- induced weight gain: a comprehensive research synthesis.Am J Psychiatry 2019;156:1686-1696.
Omamurhomu Olose, E., Edet, J., Chidozie God, D., & Uwakwe, R. Dislipidemia dan Hasil Medis (Kualitas Kesehatan Terkait Kesehatan) pada Pasien dengan Skizofrenia yang Menggunakan Antipsikotik di Enugu, Nigeria. Jurnal Psikiatri.2017:1(3);120-132.
Teixera PJR, Rocha FL. Metabolic side effects of antipsychotics and mood stabilizers. Review Artichle. 2016.p. 1-22
Moghadamnia M. Metabolic effect of Olanzapin medication on weight gain. Life Science journal 2017;10(3).
DOI (PDF): https://doi.org/10.30596/bf.v11i3.28213.g14620
Refbacks
- There are currently no refbacks.
JURNAL BULETIN FARMATERA
Gedung Kampus 1 Universitas Muhammadiyah Sumatera Utara (UMSU) Lantai II, Laboratorium Farmakologi dan Terapi Fakultas Kedokteran UMSU Jalan Gedung Arca No. 53 Medan Sumatera Utara Indonesia, Kode Pos 20217.
Contact (WA): 0812-6208-2844
E-mail: farmatera@umsu.ac.id

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

